Isoprinosine (Inosine Pranobex)

Inosine Pranobex works by stimulating T‑lymphocyte activity and increasing cytokine production, which enhances the body’s cellular immunity. It also interferes with viral replication mechanisms, providing a direct antiviral effect across a broad spectrum of viruses.

The dosage of Isoprinosine is individualized and must be determined by a qualified prescriber based on the specific indication, patient age, weight, renal and hepatic function, and other clinical factors. Patients should follow the prescribing physician’s instructions and not adjust the dose on their own.

Safety data for Isoprinosine during pregnancy and lactation are limited. It should only be used if the potential benefit justifies the possible risk to the fetus or infant. Healthcare providers usually advise caution and may recommend alternative therapies when safer options are available.

To order Isoprinosine, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials. The sales team then replies with pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Unlike many antivirals that target a specific viral enzyme, Isoprinosine combines direct antiviral activity with immune modulation. This dual mechanism can be advantageous in infections where host immunity plays a key role, but it may not replace virus‑specific agents such as acyclovir for herpes or oseltamivir for influenza in all cases.

Isoprinosine tablets should be stored at ambient temperature, below 25 °C, in the original packaging to protect from moisture and light. Keep the product out of reach of children and avoid storing in humid or excessively hot environments.

Isoprinosine is administered orally, typically as a tablet taken with water. The exact dosing schedule, including frequency and duration, is prescribed by the treating physician based on the individual’s clinical condition.

Serious adverse reactions, although rare, include severe allergic responses such as anaphylaxis, significant liver enzyme elevations, blood dyscrasias (e.g., leukopenia, thrombocytopenia), and severe skin reactions like Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they experience symptoms such as rash spreading, difficulty breathing, jaundice, or unexplained bruising.

Isoprinosine is contraindicated in individuals with known hypersensitivity to Inosine Pranobex or any excipients in the formulation. Caution is advised for patients with severe hepatic or renal impairment, and it should be avoided in those receiving live vaccines or potent immunosuppressive therapy unless specifically directed by a physician.